Merck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strength
7 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
5 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 5 separate news trends connected to Keytruda, spanning August 19, 2026 through October 29, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 38 article observations and 36 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
7 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Moderna and Merck's mRNA cancer vaccine win marks a new treatment era.
Inhibrx’s breakthrough OX40 data lifted response rates yet left the market oddly unimpressed.
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Shares of Moderna have doubled after its cancer vaccine trial with Merck met key endpoints.